search
Back to results

Randomized Control Trial to Evaluate Effectiveness of a Case Managment Program Regarding Psychosocial Well-being and Disease Symptoms Health for Patients With Multimorbid Coronary Heart Disease (CHD) Patients (KHK ProMA) (KHK ProMA)

Primary Purpose

Coronary Heart Disease, Multimorbidity

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Case Management "CM CHD"
Social Interaction
Sponsored by
Genossenschaft Gesundheitsprojekt Mannheim e.G
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Coronary Heart Disease focused on measuring Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support

Eligibility Criteria

30 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosed CHD

    • participation in the Disease Management Program (DMP) of CHD or
    • a risk score (Framingham or Procam) higher than 20%
  • two additional chronic diseases (multimorbid)

Exclusion Criteria:

  • Patients living in institutionalized care
  • Patients having dementia
  • Patients associated with a life expectancy of less than one year
  • Patients who are not able to communicate in German language

Sites / Locations

  • Genossenschaft Gesundheitsprojekt Mannheim e.G.

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

No Intervention

Arm Label

Case Management "CM CHD"

Social Interaction

Control Group

Arm Description

The intervention consists of a biweekly telephone or personal contact by trained case managers over the first 6-months and monthly contact over the second 6-months to assess well-being, everyday life (positive, neutral and negative daily events), and to inquire after health and personal problems on which basis the case manager offers practical or emotional support or a referral to the general practitioner if deemed necessary. During the contacts also medical control measures like blood pressure or weight are taken, and other study outcome measures like need for medical treatment.

Identical as the CM CHD group, but with exclusion of medical control measures.

Patients assigned to the control group received usual care (no additional contact/support) and therefore stays under the standard supervision of the general practitioner i.e. as participant in the normal disease management program for CHD (quarterly check-ups).

Outcomes

Primary Outcome Measures

Change in health outcomes
This includes biomarkers (blood pressure, BMI, weight, blood lipids), physical balance performance (semi tandem stand), care utilization and medication usage, clinical assessments and need for (medical) treatment (like dyspnea, fatigue, care, vomitus, thirst, lack of appetite, nausea, disorientation). Within the intervention group CM CHD weight and blood pressure is self-reported by patients biweekly within the first six months and monthly within the second six months.
Change in quality of life
We will measure this variable using the "EQ-5D" and two additional items.

Secondary Outcome Measures

Change in Loneliness
We will measure this variable using the "Hamburger Einsamkeits-Skala (HES)" a German version of the UCLA-Loneliness Scale.
Change in Depression
We will measure this variable using the "Patient Health Questionnaire - 9 item (PHQ-9) instrument".
Change in self-efficacy
We will measure this variable using the "SWE" questionnaire as well as items of self-efficacy regarding sports, quit smoking and healthier eating behavior.
Change in social support
We will measure this variable using the "Skala sozialer Unterstützung bei Krankheit (SSUK)". This instrument consists of two subscales, supportive behavior as well as stressful interactions.
Change in health locus of control
We will measure this variable using the "MHLC-C". This instrument consists of four subscales, internal, chance, doctors and other people.
Change in lifestyle behavior
This includes smoking, alcohol consumption, eating habits and physical activity.
Change in social network of family and friends
This includes the number of closer family members and friends and the amount of contact with them.
Change in outcome expectancies
This includes items regarding sports, quit smoking and healthier eating behavior.
Change in vulnerability
This includes the total vulnerability regarding specific diseases for one's own person as well as for a peer/other person. Thus the relative vulnerability can be determined.
Change in intention
This includes items of intentions for a healthier lifestyle like more physical activity, quit smoking and healthier eating behaviors.
Change in severity
This includes the estimated severity of different cardiovascular diseases in general as well as their severity for the own individual.
Change in health worries
This includes worries about the own health in general as well as regarding specific health problems like blood pressure, high cholesterol or the risk of a myocardial infarction.
Change in cognitive functions
This will be measured using the Mini-mental Status Exam and the Clock Drawing Test.

Full Information

First Posted
November 8, 2012
Last Updated
November 9, 2012
Sponsor
Genossenschaft Gesundheitsprojekt Mannheim e.G
Collaborators
Merck Sharp & Dohme LLC, pfm medical Institute gGmbH, Germany, Heidelberg University
search

1. Study Identification

Unique Protocol Identification Number
NCT01725074
Brief Title
Randomized Control Trial to Evaluate Effectiveness of a Case Managment Program Regarding Psychosocial Well-being and Disease Symptoms Health for Patients With Multimorbid Coronary Heart Disease (CHD) Patients (KHK ProMA)
Acronym
KHK ProMA
Official Title
Koronare Herzkrankheit Projekt Mannheim
Study Type
Interventional

2. Study Status

Record Verification Date
November 2012
Overall Recruitment Status
Unknown status
Study Start Date
July 2011 (undefined)
Primary Completion Date
December 2012 (Anticipated)
Study Completion Date
March 2013 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Genossenschaft Gesundheitsprojekt Mannheim e.G
Collaborators
Merck Sharp & Dohme LLC, pfm medical Institute gGmbH, Germany, Heidelberg University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This randomized controlled trial (RCT) will examine a case management program for patients suffering from coronary heart disease with multimorbidity in Mannheim, Germany. The trail consists of 3 treatment arms: 1) intensified case management; 2) social interaction alone 3) standard care. The main objectives are to evaluate how case management and social interaction alone compared to standard medical care affect the primary and secondary outcomes: physical health, quality of life, loneliness, depression, self-efficacy, outcome expectancies, social support, health locus of control, lifestyle behavior, social network, vulnerability, intention, severity, health worries and cognitive functions.
Detailed Description
This randomized controlled trial (RCT) will examine a case management program for 320 male and female patients suffering from coronary heart disease with multimorbidity in Mannheim, Germany. The main objectives are to evaluate how case management and social interaction alone compared to standard medical care affect the primary and secondary outcomes: physical health, quality of life, loneliness, depression, self-efficacy, outcome expectancies, social support, health locus of control, lifestyle behavior, social network, vulnerability, intention, severity, health worries and cognitive functions. Additionally, the secondary outcomes are studied as factors that mediate the effects of case management and social interaction alone compared to standard medical care on the primary outcomes. The trail consists of 3 treatment arms: 1) intensified case management; 2) social interaction alone 3) usual care. The intervention consists of a biweekly contact by trained case managers over the first 6-months and a monthly contact over the subsequent 6-months. Each contact involves an assessment of well-being, daily life, problems and offering emotional support and solutions or refer to the general practitioner if necessary (both intervention groups). For patients assigned to the "CM CHD" the contacts include medical control (like blood pressure or weight) and well-being as well as an additional core set of relevant outcome measures (e.g. need for treatment of fatigue). Patients assigned to the control group received usual care (no CM or contact). An additional fourth group is monitored. This group is consisting of patients who refused to take part in the study but gave consent to collect their practice data (not randomized). Each patient will be followed for 12 months. Extensive assessments and self-administered questionnaires take place at baseline, 6-month and 12-month for all patients in the three randomized groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Heart Disease, Multimorbidity
Keywords
Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
320 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Case Management "CM CHD"
Arm Type
Experimental
Arm Description
The intervention consists of a biweekly telephone or personal contact by trained case managers over the first 6-months and monthly contact over the second 6-months to assess well-being, everyday life (positive, neutral and negative daily events), and to inquire after health and personal problems on which basis the case manager offers practical or emotional support or a referral to the general practitioner if deemed necessary. During the contacts also medical control measures like blood pressure or weight are taken, and other study outcome measures like need for medical treatment.
Arm Title
Social Interaction
Arm Type
Experimental
Arm Description
Identical as the CM CHD group, but with exclusion of medical control measures.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Patients assigned to the control group received usual care (no additional contact/support) and therefore stays under the standard supervision of the general practitioner i.e. as participant in the normal disease management program for CHD (quarterly check-ups).
Intervention Type
Behavioral
Intervention Name(s)
Case Management "CM CHD"
Intervention Description
Patients, who are randomized to the intervention group, will receive case management from a trained and experienced physician assistant. The case manager will carry out following tasks: Biweekly/monthly telephone consultations or home visits Identification of health or personal problems of the patient Monitoring of medical parameters Coordination of contact with health care providers if necessary Support to the patient related to health status and environmental changes Promote disease-self management through coaching Counseling, that is focused on emotional support and active listening
Intervention Type
Behavioral
Intervention Name(s)
Social Interaction
Intervention Description
Identical as the CM CHD group, but with exclusion of medical control measures and the medical aspects.
Primary Outcome Measure Information:
Title
Change in health outcomes
Description
This includes biomarkers (blood pressure, BMI, weight, blood lipids), physical balance performance (semi tandem stand), care utilization and medication usage, clinical assessments and need for (medical) treatment (like dyspnea, fatigue, care, vomitus, thirst, lack of appetite, nausea, disorientation). Within the intervention group CM CHD weight and blood pressure is self-reported by patients biweekly within the first six months and monthly within the second six months.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in quality of life
Description
We will measure this variable using the "EQ-5D" and two additional items.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Secondary Outcome Measure Information:
Title
Change in Loneliness
Description
We will measure this variable using the "Hamburger Einsamkeits-Skala (HES)" a German version of the UCLA-Loneliness Scale.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in Depression
Description
We will measure this variable using the "Patient Health Questionnaire - 9 item (PHQ-9) instrument".
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in self-efficacy
Description
We will measure this variable using the "SWE" questionnaire as well as items of self-efficacy regarding sports, quit smoking and healthier eating behavior.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in social support
Description
We will measure this variable using the "Skala sozialer Unterstützung bei Krankheit (SSUK)". This instrument consists of two subscales, supportive behavior as well as stressful interactions.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in health locus of control
Description
We will measure this variable using the "MHLC-C". This instrument consists of four subscales, internal, chance, doctors and other people.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in lifestyle behavior
Description
This includes smoking, alcohol consumption, eating habits and physical activity.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in social network of family and friends
Description
This includes the number of closer family members and friends and the amount of contact with them.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in outcome expectancies
Description
This includes items regarding sports, quit smoking and healthier eating behavior.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in vulnerability
Description
This includes the total vulnerability regarding specific diseases for one's own person as well as for a peer/other person. Thus the relative vulnerability can be determined.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in intention
Description
This includes items of intentions for a healthier lifestyle like more physical activity, quit smoking and healthier eating behaviors.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in severity
Description
This includes the estimated severity of different cardiovascular diseases in general as well as their severity for the own individual.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in health worries
Description
This includes worries about the own health in general as well as regarding specific health problems like blood pressure, high cholesterol or the risk of a myocardial infarction.
Time Frame
Measured at baseline, 6 and 12 months follow-up
Title
Change in cognitive functions
Description
This will be measured using the Mini-mental Status Exam and the Clock Drawing Test.
Time Frame
Measured at baseline, 6 and 12 months follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed CHD participation in the Disease Management Program (DMP) of CHD or a risk score (Framingham or Procam) higher than 20% two additional chronic diseases (multimorbid) Exclusion Criteria: Patients living in institutionalized care Patients having dementia Patients associated with a life expectancy of less than one year Patients who are not able to communicate in German language
Facility Information:
Facility Name
Genossenschaft Gesundheitsprojekt Mannheim e.G.
City
Mannheim
State/Province
BW
ZIP/Postal Code
68259
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

Randomized Control Trial to Evaluate Effectiveness of a Case Managment Program Regarding Psychosocial Well-being and Disease Symptoms Health for Patients With Multimorbid Coronary Heart Disease (CHD) Patients (KHK ProMA)

We'll reach out to this number within 24 hrs